Pharmacy Times®
Specialty Pharmacy Times
  • Keeping an Eye on Hepatitis C Virus Drug Approvals
  • Community Specialty Pharmacy: The Time Is Now!
  • Specialty Pipeline Highlights
  • Evaluating and Elevating Specialty Pharmacists Through Certification
  • How Will Specialty Pharmacy Be Affected By Cost Containment?
  • Psoriatric Arthritis: An Overview
Genetic Biomarkers Help to Better Predict Prostate Cancer Risk
Davy James, Associate Editor
Researchers find 23 new prostate cancer risk sites on the genome.
Managed Health Care Associates Releases New White Paper on Important Role of Post-Acute Care Provider within an ACO
Paper also offers insight from specific case studies into the ACO-PAC Engagement Spectrum.
Medical Supplies Flood into Sierra Leone During Ebola Quarantine
Davy James, Associate Editor
Efforts to contain the virus increase as death toll continues to rise.
Opsumit by Actelion Pharmaceuticals US, Inc
Michael R. Page, PharmD, RPh
Opsumit (macitentan) was approved to reduce the risk of hospitalization and delay disease progression in patients with WHO group I pulmonary arterial hypertension.
Zydelig by Gilead Sciences, Inc
Michael R. Page, PharmD, RPh
The FDA has approved Zydelig (idelalisib) tablets for the later-line treatment of 3 types of cancer, including chronic lymphocytic leukemia, follicular B-cell non-Hodgkin lymphoma, and small lymphocytic lymphoma.
Featured Video
The Path to Specialty Pharmacy
Michael Nameth, RPh, MBA, chief executive officer of Aureus Health Services, discusses information people entering the field of specialty pharmacy need to know.
Industry Guide
We've created this Industry Guide with close to 300 companies and organizations as a one-stop guide for industry stakeholders in the specialty pharmacy space.
Current Issue
Volume: 5
Number: 4
Conference Calendar
â—„        September 2014        â–º
Featured Company Profile
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Pharmacy Times 2006-2013
Intellisphere, LLC. All Rights Reserved.